Article
Integrative proteomics, genomics, and translational immunology approaches reveal mutated forms of Proteolipid Protein 1 (PLP1) and mutant-specific immune response in multiple sclerosis.
Proteomics - 1 Mar 2017
Qendro Veneta, Bugos Grace A, Lundgren Debbie H, Glynn John, Han May H, Han David K
Abstract excerpt
In order to gain mechanistic insights into multiple sclerosis (MS) pathogenesis, we utilized a multi-dimensional approach to test the hypothesis that mutations in myelin proteins lead to immune activation and central nervous system autoimmunity in MS. Mass spectrometry-based proteomic analysis of human MS brain lesions revealed seven unique mutations of PLP1; a key myelin protein that is known to be destroyed in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.